Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value [Yahoo! Finance]
Kestra Medical Technologies (NASDAQ:KMTS) was given a new $24.00 price target on by analysts at The Goldman Sachs Group, Inc..
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery
Kestra Medical Technologies (NASDAQ:KMTS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]